What Dante Genomics does

Dante Genomics, doing business as Dante Omics (also historically Dante Labs), operates a multi-omics solutions platform delivering clinical-grade genomic sequencing and AI-powered interpretation. The product portfolio spans Whole Genome Sequencing, Whole Exome Sequencing, transcriptomics, proteomics, epigenetics, metagenomics, single-cell sequencing, spatial sequencing, long-read sequencing (Oxford Nanopore and PacBio), GWAS, and specialized clinical applications including oncology, liquid biopsy, solid tumor profiling, minimal residual disease detection, pharmacogenomics, newborn screening, NIPT, and carrier screening. The platform is supported by the proprietary AVANTI NGS data analysis software and an AI GPU-accelerated multi-omics engine that the company claims delivers results in days rather than months. Additional solution offerings include "Clinical Lab in a Box" — a packaged deployment for organizations seeking in-house genomic testing capabilities — and a library of 150+ omics reports.

The company operates a B2B enterprise sales motion with quote-based, multi-year contract pricing, targeting five primary use-case segments: Diagnostics companies and clinical labs, academic and commercial Researchers (including biopharma drug discovery), Concierge Doctors offering personalized medicine, Rare Disease testing providers, and Oncology applications. Geographic reach spans 97 countries. Strategic partnerships include AWS (Generative AI for Health) and NVIDIA (GTC 2025), positioning Dante within the leading cloud and AI-compute ecosystems. The website discloses scale metrics of 1 million genomic analyses completed and 100,000+ genomic samples analyzed, but does not disclose revenue, headcount, funding history, or management team details.

Name

Dante Genomics

Legal name

Dante Omics

Website

https://dantegenomics.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Dante Omics is a multi-omics platform offering clinical-grade genomic sequencing and AI-powered interpretation across WGS, WES, transcriptomics, proteomics, and epigenetics, serving diagnostics companies, researchers, biopharma, and clinical labs in 97 countries.

Ownership category

akta.pro rank

Product category

Genomic Sequencing & Multi-omics Services

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Software Publishers (5132)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics) (HLAAANAF)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Single-Cell & Spatial Omics Services (HLAGANAC), Epigenomics & Chromatin Profiling Services (HLAGANAF), Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ), Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

Keywords

• Genomic sequencing services
• Whole genome sequencing
• Multi-omics analysis
• Bioinformatics software
• Clinical genomic testing

Headquarters

HQ city

L'aquila

HQ country

Italy

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Genomic Sequencing Services: Clinical-grade genomic sequencing services including Whole Genome Sequencing, Whole Exome Sequencing, and specialized panels for diagnostics, research, and pharmaceutical applications
2. Multi-Omics Analysis Services: Advanced multiomics analysis including transcriptomics, proteomics, epigenetics, and bioinformatics services for biopharma and research

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Dante Omics provides clinical-grade genomic sequencing and multi-omics analysis services, including Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), transcriptomics, proteomics, epigenetics, metagenomics, and single-cell and spatial sequencing. The platform combines these sequencing capabilities with an AI-powered, GPU-accelerated bioinformatics pipeline and the AVANTI NGS data analysis software to deliver interpreted genomic reports to diagnostics labs, researchers, biopharma, and healthcare institutions globally.

Product overview

Dante Omics is a multi-omics solutions platform offering a comprehensive portfolio of genomic services and AI-powered analysis. The platform operates as a unified offering combining clinical-grade sequencing (Whole Genome Sequencing, Whole Exome Sequencing), specialized applications (Oncology, Pharmacogenomics, NIPT, Newborn Screening, Carrier Screening), and advanced multi-omics services (Transcriptomics, Proteomics, Epigenetics, Metagenomics, Single-cell, Spatial Sequencing, Long Reads, GWAS). The portfolio includes the AVANTI bioinformatics software platform for NGS data analysis, and supporting solutions like Clinical Lab in a Box for in-house laboratory setup and Genomic Reports for delivering results. All services are powered by AI for interpretation and analysis, with capabilities spanning diagnostics, biopharma research, and population genomics applications.

Differentiator

Problem solved

Functional benefit

Brands

• AVANTI: NGS Data Analysis Software for genomic data processing and interpretation

Products and services

• Whole Genome Sequencing (WGS)

Quantifiable outcome

• Deliver results in days rather than months

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• NVIDIA GTC 2025coreStrategic or Co-development Partner · 1 January 2025Participation in NVIDIA GTC 2025 AI Conference for Developers, demonstrating GPU acceleration capabilities for multiomics platform. NVIDIA's AI computing platform enables advanced genomic data analysis.
• AWS | Generative AI for HealthcoreTechnology or IntegrationCollaboration with AWS for generative AI in health applications, showcasing integration with major cloud infrastructure provider for genomic data processing and analysis.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Personalis: Personalis is a clinical genomics and molecular diagnostics company offering WGS/WES and an AI-driven interpretation platform focused on oncology, including MRD and tumor profiling. It directly overlaps with Dante's oncology, liquid biopsy, and MRD services.
• Nebula Genomics: Nebula Genomics offers WGS, WES, and multi-omics interpretation with an emphasis on privacy-enabled, AI-driven analysis. It directly competes with Dante on consumer and research-oriented whole genome sequencing products and bioinformatics interpretation.
• BGI Genomics: BGI Genomics operates one of the world's largest genomic sequencing service businesses spanning WGS, WES, NIPT, oncology, and rare disease. It is the closest direct peer to Dante Omics in terms of clinical-grade sequencing service breadth, multi-omics scope, and global delivery footprint.
• Helix: Helix operates a clinical-grade sequencing platform serving health systems, biopharma, and population genomics programs, with a software and 'lab-in-a-box' style offering. Its end-to-end model and population health focus overlap significantly with Dante's clinical sequencing and Clinical Lab in a Box solution.
• Eurofins Genomics: Eurofins Genomics is a global genomic services provider offering WGS, WES, Sanger sequencing, oligonucleotides, and bioinformatics. It is a comparable direct peer in multi-omics service delivery, custom panels, and biopharma research support across many of the same geographies as Dante.
• Color Health: Color Health provides clinical-grade genetic testing across hereditary cancer, pharmacogenomics, and population health, with an enterprise sales motion to employers, providers, and biopharma. It competes with Dante's clinical sequencing, pharmacogenomics, and population genomics use cases.

Emerging players

• Element Biosciences: Element Biosciences develops novel sequencing platforms and works with service providers on multi-omics applications. While primarily an instrument vendor, its AVITI system competes in the sequencing ecosystem that Dante's AVANTI software and clinical sequencing services are built upon.

Broad incumbents

• Illumina: Illumina is the dominant NGS instrument and sequencing services provider. While primarily a platform/tools vendor, its clinical sequencing services and GRAIL-adjacent oncology efforts overlap with Dante's clinical-grade WGS/WES and oncology offerings, making it the broadest incumbent peer.
• Myriad Genetics: Myriad Genetics is an established clinical genetic testing company with a deep menu in hereditary cancer, pharmacogenomics, and rare disease. It overlaps with Dante's clinical applications including pharmacogenomics, carrier screening, newborn screening, and rare disease diagnostics.
• Tempus AI: Tempus AI combines multi-modal data, AI, and sequencing for oncology and precision medicine, including WES/WTS, liquid biopsy, and RNAseq. While broader in scope, its multi-omics + AI interpretation thesis directly parallels Dante's positioning for biopharma and clinical oncology customers.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/DanteLabs
• LinkedInlinkedin.com/company/dantegenomics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dante Genomics